A combination of Covid and market gloom results in the fewest acquisitions closing for over 20 years.
Welcome to the calm before the Covid-19 storm.
Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Transvaginal mesh implants are banned in the US, but remain a possibility in Europe.
An October curse returns to haunt Convatec, and this time it has spooked the CEO.
Big cap medtech is hiring, largely thanks to organic growth.